Drug Safety Update - July 2024
The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for July 2024 (PDF).
This issue advises clinicians about reports of ocular surface toxicity and ocular chemical injury associated with use of Epimax Ointment and Epimax Paraffin-Free Ointment. It is recommended to avoid prescribing or advising these products for use on the face. Patients should be advised to wash their hands after using these products and avoid touching their eyes. It is noted that the irritation should resolve on discontinuation but symptoms should but treatment with topical lubricants, topical antibiotics or topical steroids may be required.
Lastly, this issue contains a summary of letters to healthcare professionals in June. These generally related to supply issues and recalls.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
| « SMC Update - July 2024 | CKS Updates - July 2024 » |
Leave a Comment